Patients encountering high deductibles regarding medication in their Affordable Care Act plans can seek assistance from drug manufacturers by using copay programs, said Daniel J. Klein, president and CEO of the Patient Access Network Foundation.
Patients encountering high deductibles regarding medication in their Affordable Care Act plans can seek assistance from drug manufacturers by using copay programs, said Daniel J. Klein, president and CEO of the Patient Access Network Foundation.
Transcript (modified)
What challenges are patients running into with Affordable Care Act plans?
The exchange plans, in some ways, look a lot like Medicare Part D, particularly around medications. I say this because exchange plans have, in many cases, a separate deductible for drugs and this deductible, whether it’s separate or not, is quite high. So I think the median deductible in the exchange silver plans is probably over $3000 annually.
The other thing that’s important to understand about the exchange plans is that they do have a maximum out-of-pocket limit, but oftentimes that doesn’t really kick in until around $6700 for an individual. If you’re above the subsidy level—what’s called the “cost-sharing reduction level”—within the exchange plans (and I think that’s about 250% of federal poverty level) then between that and the maximum out-of-pocket limit, between your deductibles and out-of-pocket costs until you hit that out-of-pocket limit, you may be unable to afford to use new treatments that are available. If you can’t find that $3000 plus whatever the coinsurance is it may be very difficult for you to get access to the care you need.
Now the important thing to understand is the difference in the exchange plans, that the drug manufacturers can provide direct assistance through their copay card program. Patients may be able to get assistance in that way.
Exploring Medicare Advantage Prior Authorization Variations
March 26th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the March 2024 issue of The American Journal of Managed Care® about their findings on variations in prior authorization use across Medicare Advantage plans.
Listen
Poor Well-Being Scores Linked to Early Treatment Stoppage in Multiple Myeloma
March 27th 2024Investigators used the Functional Assessment of Cancer Therapy-General General Physical Wellbeing Scale to collect data on patient-reported treatment-related adverse effects, to provide clinicians guidance on predicting risk of early treatment discontinuation among ECOG-ACRIN E1A11 trial participants.
Read More
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
The Pivotal Role of Payers in Improving Health Equity, Maternal Health Care in the US
March 26th 2024A presentation at the Greater Philadelphia Business Coalition on Health's 2024 Women’s Health Summit discussed how payers, including employers and public entities, can strategically influence health care purchasing to prioritize maternal health and equity.
Read More